Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.
- 1 May 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 77 (5) , 1177-1184
- https://doi.org/10.1161/01.cir.77.5.1177
Abstract
To determine the normal relationship in vivo between action potential duration (APD) and effective refractory period (ERP) over a large range of steady-state cycle lengths (CLs) and to determine how a sodium channel-blocking agent, quinidine, affects this relationship, we developed a new contact electrode technique for simultaneous measurements of monophasic action potentials and refractoriness at a single site in the beating heart in situ. Recordings were made from left ventricular epicardium in open-chest dogs during steady-state pacing at CLs from 220 to 600 msec both before and after therapeutic intravenous administration of quinidine. During baseline both APD at 90% repolarization (APD90) and ERP were linearly correlated to CL with nearly identical slopes: y = 0.24x CL + 83.0 (r = 1.0; p less than .0001) for APD90 and y = 0.22x CL + 82.3 (r = 1.0; p less than .0001) for ERP. Expressed in percent repolarization, ERP coincided with a repolarization level of 79% to 83%, with no appreciable influence of CL on this relationship. Quinidine increased APD90 by a small but significant amount (8 to 12 msec), which was independent of CL. In contrast, the effect on ERP of quinidine exhibited marked frequency dependence (p less than .0002), producing progressively greater ERP increase at shorter CLs, as compared with both baseline ERP and concomitant APD90. The duration by which ERP exceeded APD90 reached 44 +/- 14 msec at a CL of 220 msec.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 36 references indexed in Scilit:
- Programmed electrical stimulation studies for ventricular tachycardia induction in humans. I. The role of ventricular functional refractoriness in tachycardia inductionJournal of the American College of Cardiology, 1986
- In vitro validation of a new cardiac catheter technique for recording monophasic action potentialsEuropean Heart Journal, 1986
- Antiarrhythmic drug classification: New science and practical applicationsThe American Journal of Cardiology, 1985
- Evaluation of a percutaneous catheter technique for ablation of ventricular tachycardia in a canine modelAmerican Heart Journal, 1985
- Use-dependent effects of amiodarone on V̇max in cardiac Purkinje and ventricular muscle fibersEuropean Journal of Pharmacology, 1985
- Frequency-Dependent Effects of Several Class I Antiarrhythmic Drugs on &OV0312;max of Action Potential Upstroke in Canine Cardiac Purkinje FibersJournal of Cardiovascular Pharmacology, 1985
- Ventricular arrhythmias: Mechanisms and actions of antiarrhythmic drugsAmerican Heart Journal, 1984
- Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassificationCardiovascular Research, 1983
- EFFECTS OF MEXILETINE ON TRANSMEMBRANE ACTION POTENTIALS AS AFFECTED BY EXTERNAL POTASSIUM CONCENTRATION AND BY RATE OF STIMULATION IN GUINEA-PIG PAPILLARY MUSCLESClinical and Experimental Pharmacology and Physiology, 1980
- Antiarrhythmic Drugs: Electrophysiological ActionsAnnual Review of Pharmacology, 1971